The Oral clinical nutrition supplement Market is valued to be around USD 14,498.1 million in 2025 and is projected to grow to USD 23,391.7 million by 2035, with a CAGR of 4.9% from 2025 to 2035.
Oral clinical nutritional supplements are oral preparations that have been expertly created to address certain valorisation of performance and specialized nutritional requirements and assist in the improvement of a medical condition.
They play a vital role in the maintenance of nutritional status in patients who are not able to get enough intake of dietary needs; these could range from nutritional support upto specific condition-specific needs.
Some of the uses include renal failure, hepatic failure, oncology nutrition, diabetes, swallowing disorders, IBD, enteral nutrition, neurological disorders, and respiratory diseases; these are usually done under medical supervision, so as to guarantee proper use and outcomes in the patient.
Leading competitors in the area of clinical nutritional health are Danone Nutricia, Abbott Nutrition, Nutrition Medica, and Medifood International to mention some since they have good hold on market shares. These companies are recognized for a large number of their products in the market and distribution networks.
The rise in awareness on how nutrition can affect the management of diseases, an aging society, the rising complexity of individual health needs, and advancement in nutritional sciences drive this market.
Besides, such things as those aiming to provide formulations toward specific medical conditions, as well as innovations and increasing demands for more palatable options, offer extra impetus to this market growth.
| Attributes | Description |
|---|---|
| Estimated Global Oral clinical nutrition supplement Industry Size (2025E) | USD 14,498.1 million |
| Projected Global Oral clinical nutrition supplement Industry Value (2035F) | USD 23,391.7 million |
| Value-based CAGR (2025 to 2035) | 4.9% |
Dysphagia Is One Key Issue Having Large Product Portfolio by Players
Dehydration is a serious condition for individuals with dysphagia; this condition is characterized by symptoms that may pose difficulties for swallowing. These patients usually find it challenging to maintain proper hydration, increasing their risk of dehydration, which can worsen other health problems.
Clinical nutritional supplements are specially designed to treat dysphagia by providing pre-thickened drinks that are safe and easy to swallow. These products ensure that patients can remain hydrated without the risk of aspiration or choking. With the increasing recognition of dysphagia's impact on patients' health, particularly in the elderly, this product category is booming.
Nutilis Aqua, on the other hand, is a drink pre-thickened for hydration and is designed for etc with dysphagia. Such patients will be able to hydrate themselves in relatively safe and easy conditions-the whole range of flavors.
Food Allergy Is Emerging Health Condition in This Area
Cow's milk allergy, especially in infants, is one common and often challenging condition to manage. Extensively hydrolyzed formulas are essential for these infants with mild-to-moderate cow's milk allergies, as they help reduce other allergic reactions by breaking down the proteins that cause sensitivity.
The increasing prevalence of food allergies, particularly in children, drives the specialty formula market for these allergies. Products targeted to cater to cow's milk allergy are vital to ensure safe and adequate nutrition for an infant when breastfeeding is impossible or irregular.
Aptamil Pepti SYNEO is manufactured for the dietary management of mild-to-moderate cow's milk allergy in infants; it is an extensively hydrolyzed infant formula developed by Danone Nutricia. It contains a combination of beneficial probiotics and prebiotics in order to facilitate complete nutrition for the infants allergic to cow's milk.
Disease Related Malnutrition on the Growth
Nutrient absorption or utilization deficit due to chronic disease or malnutrition, surgical procedures, etc. Such deficiency may result in muscle loss and fatigue along with lowered immune system efficacy.
Key organ diseases such as cancer, gastrointestinal, and neurological diseases have increased the market demand for specialized nutrient enriched products to address the dietary needs of the malnourished people This is an oral nutritional supplement that if combined with other treatments such as exercise during therapy, will assist in the general improvement of a patient that suffers from protein energy malnutrition.
| Particular | Value CAGR |
|---|---|
| H1 | 4.6% (2024 to 2034) |
| H2 | 4.4% (2024 to 2034) |
| H1 | 5.1% (2025 to 2035) |
| H2 | 5.3% (2025 to 2035) |
The supplements industry is expected to grow steadily with notable half-yearly compound annual growth rates (CAGR). From 2024 to 2034, H1 shows a growth rate of 4.6%, while H2 is slightly lower at 4.4%. Moving to the 2025 to 2035 period, H1 is projected to grow at 5.1%, indicating a positive trend. In H2 growth for the same period is slightly higher at 5.3%.
From 2020 to 2024, the global market for oral clinical nutritional supplements experienced significant growth, driven by increasing awareness of their role in addressing malnutrition and chronic conditions.
The COVID-19 pandemic further accelerated demand as more individuals relied on these supplements to support immune health and recovery. The market also witnessed innovation in formulations, catering to specific dietary needs such as dysphagia, oncology nutrition, and food allergies.
Brands like Boost®, Ensure®, and Glucerna® gained prominence for offering a diverse range of products targeting different health conditions. Consumer preferences for high-protein, low-sugar, and lactose- or gluten-free options also influenced product development, making these supplements more accessible and tailored to individual needs.
The oral clinical nutrition supplement market is poised for continued growth from 2025 to 2035, underpinned by an aging population, increasing prevalence of chronic diseases, and rising healthcare awareness globally. Advancements in personalized nutrition and plant-based formulations are expected to shape the industry’s future.
Demand for products catering to specialized needs, such as fibre-enriched, pre-thickened, or hypoallergenic supplements, will likely expand. Innovative delivery formats, improved taste profiles, and sustainable packaging are predicted to enhance consumer appeal.
The integration of functional ingredients like omega-3s, prebiotics, and probiotics will further drive growth, offering targeted health benefits to meet evolving consumer expectations.
Tier 1 MNCs purely dominate the global oral clinical nutrition supplement industry; in sheer collective terms, their direct share comes to 65%-70% of the market. Player manufacturers in this field range from Abbott Nutrition, Danone Nutricia, Nestle Health Science.
They not only compete with each other for sales, but are also assist in the producer price-setting and direct market trends and consumer expectations. Big portfolios of products, strong distribution networks, and commitment to R&D allowed them a competitive advantage and thus were able to address myriad nutritional needs through various countries
By contrast, Tier 3 players have little presence in the market and contribute about 5%-8% to the share of the entire market. These are small companies usually operating in niche segments or in sub-regional markets that have been struggling to expand their business and assert themselves against bigger players.
The remaining shares of the market are held by Tier 2 players, who work on balancing local expertise and global aspirations. Such a market structure denotes high concentration and the dominance of multinational corporations in the global oral clinical nutrition supplement industry.
The following table shows the estimated growth rates of the top three territories. USA, Germany and India are few attractive countries to look upon.
| Countries | CAGR 2025 to 2035 |
|---|---|
| USA | 5.4% |
| Germany | 4.5% |
| India | 6.3% |
The oral nutritional supplement market has been expanding due to increased consumer demand for diverse and convenient product formats. The latest survey says that 68% of ONS consumers prefer ready-to-drink formats like milkshakes and juice-type supplements because of their convenience and portability.
In contrast, only 52% of caregivers reported recommending high-energy powders or soup-like supplements for patients needing customized energy intake. Broadly, ONS options such as thickened liquids for dysphagia, protein-enriched jellies, and low-volume high-concentration shots respond to these varying nutritional needs among patients.
In survey after survey, 71% of customers say flavor and taste variety are the most important factors in the ONS selection process, confirming the increased desire for supplements that taste good and are pleasurable.
Together with the fastening of nutritional care at home, the need for high-protein supplementation has sharply increased by 83% among individuals actively engaged in sports or recovery, permitting even faster adaptation. These factors highlight the need for diversity and personalization in formats of ONS to manage dietary needs in clinical and therapeutic situations.
The USA oral nutritional supplement market is experiencing rapid growth due to increasing demand for plant-based and vegan options, driven by a strong consumer focus on sustainability and natural ingredients.
According to recent studies, 37% of consumers actively seeking plant-based alternatives, reflecting a significant shift in dietary preferences. Products like Kate Farms' range of all-vegan, plant-based formulas in appealing flavors have garnered widespread acceptance, offering a sustainable solution for those with dietary restrictions or preferences.
Similarly, Nestlé’s Compleat® Plant-Based & Vegan Blends, featuring certified organic whole food formulas made with real fruits and vegetables, cater to consumers prioritizing natural and organic nutrition.
These innovations align with the health-conscious German market's emphasis on clean-label claims and environmental responsibility, making plant-based oral nutritional supplements a key growth driver in the country.
India's oral nutritional supplement market is expanding rapidly, driven by rising awareness about clinical nutrition's role in managing chronic diseases such as diabetes, cardiovascular conditions, and cancer.
With approximately 77 million diabetics in India, there is a growing demand for targeted nutritional products like Glucerna®, which are designed to support blood sugar management. Similarly, the prevalence of malnutrition among cancer patients has fueled interest in oncology-focused supplements.
Additionally, India’s healthcare professionals are increasingly recommending oral nutritional supplements to bridge dietary gaps, especially for elderly patients and individuals recovering from illnesses.
The expanding availability of these products in pharmacies, hospitals, and online platforms, coupled with competitive pricing tailored to the Indian market, has further driven their adoption. This heightened focus on clinical nutrition highlights the growing recognition of these supplements as essential tools in therapeutic and preventive healthcare across the country.
| Segment | Indication - Disease Related Malnutrition |
|---|---|
| Value Share (2025) | 32.6% |
The disease-related malnutrition (DRM) segment is projected to account for a significant 32.6% value share of the global oral nutritional supplement market by 2025.
This growth underscores the critical role of ONS in addressing nutritional deficiencies among patients suffering from chronic diseases, post-surgical recovery, and age-related conditions. With increasing awareness of the impact of malnutrition on patient outcomes, healthcare professionals are prioritizing tailored nutritional support to improve recovery rates and enhance quality of life.
Key players in the market are innovating to meet the needs of this segment. For example, products like Fortimel Advanced by Nutricia, which combines high protein and specialized nutrients like ActiSyn™ to combat muscle loss, are gaining traction.
Additionally, the growing aging population and prevalence of chronic conditions globally further fuel the demand for advanced nutritional solutions in this segment, positioning DRM as a cornerstone of the ONS industry
| Segment | Channel - Prescription-based |
|---|---|
| Value Share (2025) | 69.5% |
The prescription-based channel is expected to dominate the oral nutritional supplement (ONS) market, accounting for 69.5% of the value share by 2025. This channel's growth is driven by healthcare professionals increasingly recommending specialized ONS for patients with specific medical conditions, such as disease-related malnutrition, cancer, diabetes, and dysphagia.
Prescription-based supplements offer a tailored approach, providing targeted nutrition to support recovery, improve patient outcomes, and manage chronic diseases effectively.
Prescribed by doctors and dietitians, these supplements are often part of a comprehensive care plan, ensuring that patients receive the appropriate nutrients in the correct quantities. Leading brands such as have established strong partnerships with healthcare providers, ensuring that their products are frequently recommended for managing conditions like malnutrition and diabetes.
The high value share of the prescription-based segment reflects the growing recognition of the importance of clinical nutrition in modern healthcare, particularly in hospital and clinical settings where personalized nutrition is critical for patient recovery and management of complex health issues.
The global oral nutritional supplement (ONS) market is characterized by intense competition, driven both by multinational giants and regional players seeking to capture a share of the clinical nutrition market that is becoming more popular in the years to come.
With many multinational corporations, which possess financial capabilities, expansive product portfolios, and global distribution networks, leading several large companies and thus creating a leading market, the leaders are Abbott Nutrition, Nestlé Health Science, and Danone Nutricia; these are actually rivals in desigible products with a substantial market share; hence are still innovating within the segment.
Abbott Nutrition is a clear leader with its well-known brands Ensure®, which provide a wide range of products tailored to meet specific nutritional needs for various health conditions. Abbott's prime focus on research and development (R&D) has allowed it to develop new products, such as low-sugar options and plant-based formulas, which are designed to meet the rising demand for healthier and more sustainable alternatives.
Nestle Health Science certainly plays a serious part in the market with its lines of products, Boost® and Glucerna®, which are beyond dietary support-target. Nestlé's penetration into clinical nutrition must reveal great trust among healthcare professionals that shape momentum in prescription segment.
Danone Nutricia, with its famous brands Fortimel® and Neocate®, is also a very major player. With its approach to specialized medical nutrition for disease-related malnutrition and pediatric care, Nutricia has made a mark as an important name in this market.
Danone has heavily invested in innovations and sustainability, obviously promoting plant-based formulas and organic ingredients in response to rising consumer awareness toward health and environmental issues.
While multinational corporations dominate the market, regional players also hold niche positions in specific markets. These players often focus on local preferences, cost-effective pricing strategies, and customization to meet the needs of specific health conditions or dietary preferences.
Kate Farms, for example, has carved out a position in the plant-based nutritional supplement segment, offering vegan and organic products, which are gaining popularity due to the increasing trend toward plant-based diets.
The competition in the ONS market is also influenced by emerging trends such as the growing focus on personalized nutrition, the rising demand for clean-label products, and advancements in e-commerce.
Companies are increasingly developing specialized products, such as low-sugar, gluten-free, and high-protein supplements, to cater to the evolving consumer preferences. For example, the rise of personalized ONS that cater to specific health conditions or lifestyle choices is fueling growth in the market.
Players are also differentiating themselves through innovative packaging and flavors, such as cold-serve options and products designed for people with swallowing difficulties.
Moreover, partnerships with healthcare providers, hospitals, and clinics are crucial for market penetration, especially in prescription-based segments. Companies are working closely with dietitians and doctors to ensure their products are recommended to patients as part of clinical nutrition plans.
The competition is expected to intensify as new players enter the market, particularly with a focus on plant-based, sustainable, and personalized nutrition products. The ongoing innovation and strategic partnerships will continue to shape the market, with multinational corporations striving to maintain their leadership while regional players aim to capture niche segments.
As per form, the industry has been categorized Standard Formula, Specialized Formula
This segment is further categorized into Disease-Related Malnutrition (DRM), Renal Disorders, Hepatic Disorders, Oncology Nutrition, Diabetes, Dysphagia, IBD & GI Tract Disorders, Neurological Disorders, Respiratory Orders, Others
As per form, the industry has been categorized into Liquid, Semi-solid, and Powder
Prescription-based, Over-the-Counter are two Sales channel covered in scope.
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
The global industry is estimated at a value of USD 14,498.1 million in 2025.
The North America territory is likely to hold noteworthy revenue over the forecast period.
The industry is projected to grow at a forecast CAGR 4.9% from 2025 to 2035.
Prominent players in the landscape include NUTRICIÓN MÉDICA SL.; Medtrition Inc.; Baxter International Inc.; B. Braun Melsungen AG.; Fresenius Kabi AG; Mead Johnson & Company, LLC; Abbott Laboratories; Danone Nutricia; Cambrooke Therapeutics, Inc.; GlaxoSmithKline plc; Nestlé S.A.; Kate Farms, Inc.; Perrigo Company plc; Sichuan Kelun Pharmaceutical Co., Ltd.; AYMES International Ltd.; Pfizer Inc.; Medifood GmbH. Otsuka Holdings Co., Ltd.
Explore Similar Insights
Oral Clinical Nutrition Supplement Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
